Swar Vimawala
Papers
2
Total Citations
45
H-Index
2
About
Dr. Swar Vimawala is a surgical oncologist whose research focuses on the intersection of head and neck cancer, transoral robotic surgery (TORS), and patient outcomes. His major contributions center on refining treatment paradigms for human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC). In his most-cited work, "Evaluating the impact of smoking on disease‐specific survival outcomes in patients with human papillomavirus–associated oropharyngeal cancer treated with transoral robotic surgery" (2020, 38 citations), Dr. Vimawala demonstrated that smoking significantly worsens prognosis even in HPV-positive patients treated with TORS, challenging the assumption that nonsurgical chemoradiation is the sole driver of this disparity. This study has become a key reference for risk stratification in de-escalation trials. Additionally, his investigation into "Risk factors for gastrostomy tube dependence in transoral robotic surgery patients" (2021, 7 citations) provides critical insights into functional outcomes, identifying predictors of swallowing dysfunction that guide postoperative care. Dr. Vimawala’s work bridges surgical innovation with personalized medicine, offering evidence to optimize both survival and quality of life for head and neck cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2